Clinical Trial Update: Is Eovist Suitable for Arterial-Phase MR Imaging of Liver [NA]

View source ↗

Summary

A completed clinical trial evaluates whether the MRI contrast agent Eovist (gadoxetate disodium) is suitable for arterial-phase liver imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• EOVIST (GADOXETATE DISODIUM)

Snippet

Sponsor: University of Michigan | Conditions: Liver Disease | NA | Status: COMPLETED